Brokerage Firm Rating Update on Gevo (GEVO)

Gevo (GEVO) : Zacks Investment Research ranks Gevo (GEVO) as 2, which is a Buy recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 2 research analysts is 2, which indicates as a Buy.

Gevo (GEVO) : Currently there are 2 street experts covering Gevo (GEVO) stock. The most bullish and bearish price target for the stock is $4 and $1 respectively for the short term. The average price target of all the analysts comes to $2.5. The estimated standard deviation from the target is $2.12.


Company shares have received an average consensus rating of Hold for the current week

Gevo (NASDAQ:GEVO): The stock opened at $0.7211 and touched an intraday high of $0.7983 on Wednesday. During the day, the stock corrected to an intraday low of $0.6723, however, the bulls stepped in and pushed the price higher to close in the green at $0.7 with a gain of 19.05% for the day. The total traded volume for the day was 44,297,662. The stock had closed at $0.588 in the previous trading session.

Gevo, Inc. (Gevo) is a renewable chemicals and biofuels company. The Compnay is focused on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The Company operates through two segments: the Gevo, Inc. and the Gevo Development/Agri-Energy. The Gevo, Inc. segment is responsible for all research and development activities related to the production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. The Gevo Development/Agri-Energy Segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.